5 ms·
So, the Oxford vaccine stated "... no hospitalised or severe cases ..." The Pfizer press release states: "There were 10 severe cases of COVID-19 observed in th
by camkego 6y ago
So, the Oxford vaccine stated "... no hospitalised or severe cases ..."
The Pfizer press release states:
"There were 10 severe cases of COVID-19 observed in the trial, with nine of the cases occurring in the placebo group and one in the BNT162b2 vaccinated group."
So, zero severe cases for Oxford, and one for Pfizer.
Interesting.
Should also point out the Pfizer trial may have had 43,000 participants, and the Oxford one 24,000, so they are different size trials.
Also, it's super easy to miss important details when comparing outcomes like
this, to do this properly really requires a project or in-depth investigation,
not my 15-minutes research effort. :)
Pfizer release:
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine https://www.pfizer.com/news/press-release/press-release-deta...
- andi999 6y ago"So, zero severe cases for Oxford, and one for Pfizer. Interesting." What is interesting? That they probably both have the same rate, and we are seeing a statistical fluctuation because of the low sample number?
- foota 6y agoProbably that they're both really low?
- ggm 6y agoThe statistical difference between 25,000 and 43,000 samples being... small. Basically, any effect visible at less than 2 in 40,000 might be missed by the 25,000 test. Seriously, do you think this is a huge difference in quality of measurements?